Long-term outcome of idiopathic steroid-resistant nephrotic syndrome in children

Aya Inaba(Yokohama City University Medical Center), Masataka Honda(Rikkyo University), Tomoyuki Sakai(Tokyo Metropolitan Children's Medical Center), Masaaki Mori(Tokyo Medical and Dental University), Tetsuji Kaneko(Teikyo University of Science), Yuko Hamasaki(Toho University), Fumiyo Komaki(Toho University), Hiroshi Hataya(Japanese Society for Dialysis Therapy), Kenji Ishikura(Kitasato University), Riku Hamada
Pediatric Nephrology
September 2, 2015
10.1007/s00467-015-3174-7
Cited by 37

Related Papers

Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial
|The Lancet|2014|450
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|278
Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease
|Clinical and Experimental Nephrology|2013|267
High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD)
|Circulation|2018|242
Epidemiology of pediatric chronic kidney disease/kidney failure: learning from registries and cohort studies
|Pediatric Nephrology|2021|149